Market Place
Sourcing Support
Multiply Labs and Akron Partner to Automate Use of Liquid Cytokines
20 Dec 2023 //
BUSINESSWIRE
Akron gets Eligibility Confirmation from PMDA for fibronectin
21 Jan 2023 //
PHARMABIZ
Akron Bio Receives Eligibility Confirmation from PMDA in Japan for Fibronectin
17 Jan 2023 //
BUSINESSWIRE
Akron Bio Appoints Christopher Murphy as Chief Executive Officer
12 Dec 2022 //
BUSINESSWIRE
Akron Bio Announces Launch of its Closed System Solutions line
14 Apr 2022 //
BUSINESSWIRE
Akron Bio Expands Commercialization of Advanced Gene Therapy, Vaccine Production
13 Apr 2022 //
BUSINESSWIRE
Akron BioProducts and Vor Bio to Collaborate on Nucleases
22 Mar 2022 //
BUSINESSWIRE
Akron Biotech, Octapharma enter Human AB Serum global production deal
21 Jan 2021 //
PHARMACEUTICAL-TECHNOLOGY
Akron Biotech Signs Exclusive Global Agreement with Octapharma
20 Jan 2021 //
PRESS RELEASE
Akron Biotech Signs Agreement With Synairgen plc to Supply Interferon-beta
19 Oct 2020 //
BUSINESSWIRE
Akron Bio Will Install a Cytiva FlexFactory to Manufacture Plasmid DNA
15 Oct 2020 //
PHARMTECH
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.